Navigate
X
    QualityStocks
  • 18 years ago

Novavax, Inc. (NASDAQ: NVAX)

Novavax, Inc. (NASDAQ: NVAX), a clinical stage biotechnology company, is focused on creating innovative vaccines that target a wide array of infectious diseases using advanced proprietary virus-like particle (VLP) technology. The company produces these VLP based, potent, recombinant vaccines by leveraging new and efficient manufacturing approaches. Novavax’s long-term goal is to be able to deliver a customized vaccine in the midst of an epidemic. For further information, visit the Company’s web site at www.novavax.com.

Tags Rodman & Renshaw
Related Post
  1. Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

    In the United States alone, close to one million people are living with MS, with…

  2. Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step

    California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…

  3. Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership

    The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…